News & Updates

CD40 blockade shows therapeutic potential in Sjögren's syndrome

02 Apr 2020

The novel anti-CD40 monoclonal antibody iscalimab has demonstrated clinical activity in patients with primary Sjögren's syndrome in a proof-of-concept study.

CD40 blockade shows therapeutic potential in Sjögren's syndrome

02 Apr 2020

Comorbidity type affects quality of life in PsA patients

02 Apr 2020

The type of comorbidity, rather than its number, appears to have a greater impact on the quality of life (QoL) of patients with psoriatic arthritis (PsA), a recent study has found.

Comorbidity type affects quality of life in PsA patients

02 Apr 2020

Steroid for hand OA: A potential short-term treatment option?

01 Apr 2020 by

Short-term treatment (6 weeks) with 10 mg prednisolone effectively reduces finger pain and improves function in patients who have painful hand osteoarthritis (OA) coupled with signs of inflammation, the HOPE* study has shown.

Steroid for hand OA: A potential short-term treatment option?

01 Apr 2020

Knee osteoarthritis heightens mortality risk

01 Apr 2020

Knee osteoarthritis (OA), whether symptomatic or radiographic, contributes to an increased risk of all-cause mortality, with the risk increase from symptomatic knee OA partially attributed to its effect on disability and quality of life (QoL).

Knee osteoarthritis heightens mortality risk

01 Apr 2020

Naltrexone 4.5 mg useful for treating fibromyalgia

31 Mar 2020

When treating fibromyalgia patients with low-dose naltrexone, the 4.5-mg dose appears to be a good choice, according to a recent study.

Naltrexone 4.5 mg useful for treating fibromyalgia

31 Mar 2020

$Do PPIs promote osteoporotic fractures in elderly women?$

Do PPIs promote osteoporotic fractures in elderly women?

30 Mar 2020

Proton pump inhibitors (PPIs) may increase susceptibility to osteoporotic fractures in elderly women as compared with histamine-2 receptor antagonists (H2RAs), especially those who have used PPIs for at least a year, a recent study in Korea has found.

Do PPIs promote osteoporotic fractures in elderly women?

30 Mar 2020

Tocilizumab a suitable alternative to TNFi for RA treatment

26 Mar 2020 by

The biologic disease-modifying antirheumatic drug (bDMARD) tocilizumab (TCZ), used alone or with concomitant conventional synthetic (cs) DMARDs, is an adequate alternative to a TNFi*-csDMARD regimen in patients with rheumatoid arthritis (RA), results from the TOCERRA** initiative show.

Tocilizumab a suitable alternative to TNFi for RA treatment

26 Mar 2020

Rituximab an acceptable biologic option for RA-associated bronchiectasis

25 Mar 2020

The use of rituximab in the treatment of rheumatoid arthritis (RA)-associated bronchiectasis (BR) helps stabilize or improve pulmonary symptoms, with a more favourable respiratory survival over a 5-year follow-up as compared with tumour necrosis factor inhibitors (TNFi), according to a retrospective study.

Rituximab an acceptable biologic option for RA-associated bronchiectasis

25 Mar 2020

Sprifermin keeps moving FORWARD in knee osteoarthritis treatment

25 Mar 2020 by

Post hoc results of the phase II FORWARD* study continued to reflect positive structural changes with the recombinant human fibroblast growth factor(FGF)-18 sprifermin, given the substantial dose-dependent increases in cartilage thickness gain and reductions in cartilage loss independent of location in the femorotibial joints (FTJ) of patients with knee osteoarthritis (OA).

Sprifermin keeps moving FORWARD in knee osteoarthritis treatment

25 Mar 2020

Characterizing vaginal health in women with primary Sjögren’s syndrome

24 Mar 2020

Women with primary Sjögren’s syndrome experience vaginal dryness, which contributes to sexual dysfunction and dyspareunia, as reported in a study. The dryness may be attributed to a peri-epithelial infiltration and decreased number of vascular smooth muscle cells in the vaginal wall.

Characterizing vaginal health in women with primary Sjögren’s syndrome

24 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

CD40 blockade shows therapeutic potential in Sjögren's syndrome

CD40 blockade shows therapeutic potential in Sjögren's syndrome

Comorbidity type affects quality of life in PsA patients

Comorbidity type affects quality of life in PsA patients

Steroid for hand OA: A potential short-term treatment option?

Steroid for hand OA: A potential short-term treatment option?

Knee osteoarthritis heightens mortality risk

Knee osteoarthritis heightens mortality risk

Naltrexone 4.5 mg useful for treating fibromyalgia

Naltrexone 4.5 mg useful for treating fibromyalgia

Do PPIs promote osteoporotic fractures in elderly women?

Do PPIs promote osteoporotic fractures in elderly women?

Tocilizumab a suitable alternative to TNFi for RA treatment

Tocilizumab a suitable alternative to TNFi for RA treatment

Rituximab an acceptable biologic option for RA-associated bronchiectasis

Rituximab an acceptable biologic option for RA-associated bronchiectasis

Sprifermin keeps moving FORWARD in knee osteoarthritis treatment

Sprifermin keeps moving FORWARD in knee osteoarthritis treatment

Characterizing vaginal health in women with primary Sjögren’s syndrome

Characterizing vaginal health in women with primary Sjögren’s syndrome